Anti-Hu-related epilepsy diagnosed after surgical management

J Int Med Res. 2020 Aug;48(8):300060520947914. doi: 10.1177/0300060520947914.

Abstract

Autoimmune epilepsy (AE) refers to epilepsy mediated by autoantibodies or immune cells, and a large proportion of drug-resistant epilepsy cases are classified as AE. AE lacks standardized management guidelines. At present, little research has been conducted on the effectiveness of surgical treatment of AE. This paper reports a patient whose surgical treatment was ineffective before AE was diagnosed and who improved after immunotherapy. A literature review was conducted to examine the progress of surgical treatment of epilepsy, the relationship of temporal lobe epilepsy to neuronal antibodies, surgical and prognostic factors, research progress on the anti-Hu antibody, and treatment of autoimmune encephalitis to provide a clinical reference.

Keywords: Autoimmune epilepsy; anti-Hu antibody; immunotherapy; neuronal antibodies; surgical treatment; temporal lobe epilepsy.

Publication types

  • Review

MeSH terms

  • Anticonvulsants / therapeutic use
  • Autoantibodies
  • Drug Resistant Epilepsy* / diagnosis
  • Drug Resistant Epilepsy* / drug therapy
  • Drug Resistant Epilepsy* / surgery
  • Encephalitis*
  • Epilepsy* / diagnosis
  • Epilepsy* / surgery
  • Epilepsy, Temporal Lobe* / drug therapy
  • Humans

Substances

  • Anticonvulsants
  • Autoantibodies